In this webinar, Chris Karlovich, Associate Director of the Molecular Characterization Laboratory at the Frederick National Laboratory for Cancer Research, will share key takeaways from the validation of an NGS-based comprehensive genomic profiling (CGP) liquid biopsy assay to meet the specified criteria for clinical needs. He will also discuss a retrospective analysis of clinical cohorts with the CGP ctDNA assay, which has identified clinically relevant somatic alternations with high sensitivity.
Learn:
· The value of a CGP assay from liquid biopsy samples.
· Considerations for bringing a CGP ctDNA assay in house.
· How to identify clinically relevant somatic alterations with high sensitivity using the CGP ctDNA assay in clinical cohorts.
· Lessons from entering the ctDNA and liquid biopsy field.
Your email address is never shared with third parties.